Large-Cap Indexes End Week Near Records as Deal News Builds
The S&P 500 closed just below its session high, while small caps fell for the week and five companies reported major developments.
Key takeaways
- The S&P 500 gained 1.09% for the week, ending just below its 52-week high.
- The Russell 2000 fell 1.01% for the week as volatility eased.
- Couche-Tard agreed to acquire retail assets and fuel supply arrangements from Irving Oil.
- The FDA approved Jaypirca as a first-line treatment for certain patients with CLL or SLL.
The S&P 500 rose 1.09% for the week, closing at 7,807.12 just below its 52-week high of 7,844.52. The Nasdaq Composite gained 0.58% for the week, and the Dow Jones Industrial Average added 0.81%.
Small caps lagged. The Russell 2000 fell 1.01% for the week to 2,804.34, even as it rose on Friday. The VIX ended at 14.84, down for both the day and the week.
Alimentation Couche-Tard agreed to acquire certain Irving Oil retail assets in Quebec and Ontario, along with fuel supply arrangements and 18 cardlock sites. The deal is subject to customary closing conditions and regulatory approvals. RTX’s Raytheon business secured a contract worth up to $6.3 billion for Standard Missile-3 Block IB production and sustainment.
SAP agreed to acquire AI work intelligence provider TechWolf, with closing expected in the fourth quarter of 2026, subject to conditions including regulatory approval. Canadian National Railway said it moved a record 7.94 million metric tonnes of grain from Western Canada in its third quarter.
The FDA approved Eli Lilly’s Jaypirca as a first-line treatment for certain adults with previously untreated CLL or SLL. In the trial cited by Lilly, median progression-free survival had not been reached for Jaypirca, compared with 33.5 months for the comparator arm.
This article was produced with the help of AI technology. Source: Yahoo Finance
